| Function of nuclear factor kappa B (NF-kB) in human diseases-a review M Serasanambati, SR Chilakapati South Indian Journal of Biological Sciences 2 (4), 368-87, 2016 | 235 | 2016 |
| Spatially Restricted Drivers and Transitional Cell Populations Cooperate With the Microenvironment in Untreated and Chemo-Resistant Pancreatic Cancer Nature genetics 54 (2022), 1390–1405, 2022 | 111 | 2022 |
| Antimicrobial activity of Azadirachta Indica (neem) leaf, bark and seed extracts Y Raja Ratna Reddy, C Krishna Kumari, O Lokanatha, S Mamatha, ... International Journal of Research in Phytochemistry and Pharmacology 3 (1), 1-4, 2013 | 93* | 2013 |
| Profiling single cancer cells with volatolomics approach M Serasanambati, YY Broza, A Marmur, H Haick iScience 11, 178-188, 2019 | 45 | 2019 |
| Anticancer activity of methanolic extract of Berberis aristata in MCF-7 human breast cancer cell lines M Serasanambati, SR Chilakapati, PK Manikonda, JR Kanala International Journal of Life Sciences Biotechnology and Pharma Research 4 …, 2015 | 25 | 2015 |
| Anticancer effects of brucine and gemcitabine combination in MCF-7 human breast cancer cells M Serasanambati, SR Chilakapati, PK Manikonda, JR Kanala, ... Natural Product Research 29 (5), 484-490, 2015 | 21 | 2015 |
| Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib SR Chilakapati, M Serasanambati, P Vissavajjhala, JR Kanala, ... Experimental lung research 41 (4), 173-188, 2015 | 20 | 2015 |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma Y Wu, NV Terekhanova, W Caravan, N Naser Al Deen, P Lal, S Chen, ... Nature communications 14 (1), 1681, 2023 | 16 | 2023 |
| Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice SR Chilakapati, M Serasanambati, PK Manikonda, DR Chilakapati, ... Canadian journal of physiology and pharmacology 92 (8), 631-639, 2014 | 16 | 2014 |
| Antimicrobial activity of leaf extracts of Sida cordifolia SM Reddy, CK Kumari, CS Reddy, YRR Reddy, CD Reddy International Research Journal of Pharmacy 3 (9), 309-311, 2012 | 16 | 2012 |
| Volatile compounds are involved in cellular crosstalk and upregulation M Serasanambati, YY Broza, H Haick Advanced Biosystems 3 (10), 1900131 (1 of 10), 2019 | 15 | 2019 |
| Spatial drivers and pre-cancer populations collaborate with the microenvironment in untreated and chemo-resistant pancreatic cancer DC Zhou, RG Jayasinghe, JM Herndon, E Storrs, CK Mo, Y Wu, RS Fulton, ... BioRxiv, 2021.01. 13.426413, 2021 | 13 | 2021 |
| Inhibitory effect of gemcitabine and brucine on MDA MB-231human breast cancer cells M Serasanambati, SR Chilakapati, JR Vangavaragu, DR Chilakapati International Journal of Drug Delivery 6 (2), 133-139, 2014 | 4 | 2014 |
| Curcumin potentiates antitumor effect of gemcitabine in human breast cancer in vitro M Serasanambati, SR Chilakapati, PK Manikonda, JR Kanala Current Trends in Biotechnology and Pharmacy 7 (4), 854-861, 2013 | 4 | 2013 |
| Dietary lutein attenuates bleomycin-induced pulmonary fibrosis in mice SR Chilakapati, M Serasanambati, PK Manikonda, JR Kanala Int. J. Drug Delivery 6, 380-388, 2014 | 2 | 2014 |
| 56 Vibrational spectroscopy with metasurface optics (VISMO)–a new platform for label-free spatial profiling of the tumor-immune environment K Chang, B Ogunlade, M Serasanambati, V Dolia, F Safir, J Hu, C Luna, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | 1 | 2023 |
| Toward the Development of Functional Biomarker Assays: Analysis of Neoadjuvant Intralesional Oncolytic Virus Response in High-Risk Stage II Melanoma A Kirane, D Lee, MU Ahmad, S Sharma, M Serasanambati, M Lowe, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S33-S34, 2024 | | 2024 |
| Macrophage function over phenotype determines sensitization to immunotherapy D Lee, S Sharma, M Serasanambati, MU Ahmad, B Larijani, A Kirane ANNALS OF SURGICAL ONCOLOGY 31 (1), S214-S214, 2024 | | 2024 |
| 622 Immune phenotype and iFRET functional analysis are biomarkers of response to neoadjuvant intralesional therapy for high risk stage II melanoma A Kirane, MC Lowe, MU Ahmad, S Sharma, M Serasanambati, AB Warner, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 981 AXL-targeted macrophage phenotype switching mediates checkpoint-resistance in melanoma A Kirane-c, S Sharma, M Serasanambati, MU Ahmad, C Applebee, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
